GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 13 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,000 | – | 11,875 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,070,333 | $1,156,000 | 0.07% |
| TWO SIGMA SECURITIES, LLC | 49,007 | $53,000 | 0.02% |
| ARXIS SECURITIES LLC | 11,875 | $12,000 | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 923,358 | $997,000 | 0.00% |
| Renaissance Technologies | 679,080 | $733,000 | 0.00% |
| UBS Group AG | 1,000 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 40 | $0 | 0.00% |
| CITIGROUP INC | 300 | $0 | 0.00% |
| MORGAN STANLEY | 3,000 | $4,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 100 | $0 | 0.00% |